Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India · Delayed Price · Currency is INR 945.95
-27.65 (-2.84%)
Jun 8, 2026, 3:30 PM IST
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 150.79 billion as of June 8, 2026. Its market cap has increased by 0.71% in one year.
Market Cap
150.79B
Enterprise Value
174.28B
Revenue
82.80B
Ranking
n/a
PE Ratio
37.84
Stock Price
945.95
Market Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 150.79B, an increase of 36,972.61%. That is a compound annual growth rate of 25.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 154.19B | -9.43% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 333.07B |
| Wockhardt | 312.13B |
| Piramal Pharma | 221.45B |
| Eris Lifesciences | 189.17B |
| Cohance Lifesciences | 164.92B |
| NATCO Pharma | 160.02B |
| Alembic Pharmaceuticals | 145.14B |
| Alivus Life Sciences | 126.73B |